Seeking Alpha

Amarin (AMRN -0.9%) says the European Patent Office has issued an intention to grant letter for...

Amarin (AMRN -0.9%) says the European Patent Office has issued an intention to grant letter for a patent application the company filed to protect the exclusivity of it's drug candidate, AMR101. The patent covers the drugs use in treating Hypertriglyceridemia, an indication that AMRN may seek through the European Medicines Agency. An FDA decision on the drug is due out tomorrow.
Comments (1)
  • brendoo7
    , contributor
    Comments (8) | Send Message
     
    i think its a very good push for company and god news and for investors.
    25 Jul 2012, 01:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs